U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H26N2O2.ClH
Molecular Weight 314.851
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMYDRICAINE HYDROCHLORIDE

SMILES

Cl.CCC(CN(C)C)(CN(C)C)OC(=O)C1=CC=CC=C1

InChI

InChIKey=FHHDPMSYDYZLAP-UHFFFAOYSA-N
InChI=1S/C16H26N2O2.ClH/c1-6-16(12-17(2)3,13-18(4)5)20-15(19)14-10-8-7-9-11-14;/h7-11H,6,12-13H2,1-5H3;1H

HIDE SMILES / InChI
Molecular Formula C16H26N2O2
Molecular Weight 278.3898
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

1905
13
Doses

Doses

DosePopulationAdverse events​
2 % 1 times / day single, intraurethral
Recommended
Dose: 2 %, 1 times / day
Route: intraurethral
Route: single
Dose: 2 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
Other AEs: Spasms, Cyanosis...
Other AEs:
Spasms
Cyanosis
Respiration spontaneous decreased
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
10 % 1 times / day single, intraurethral
Studied dose
Dose: 10 %, 1 times / day
Route: intraurethral
Route: single
Dose: 10 %, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
healthy, adult
Health Status: healthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
Other AEs: Generalised convulsion, Respiration spontaneous decreased...
Other AEs:
Generalised convulsion
Respiration spontaneous decreased
Cyanosis
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
AEs

AEs

AESignificanceDosePopulation
Cyanosis
2 % 1 times / day single, intraurethral
Recommended
Dose: 2 %, 1 times / day
Route: intraurethral
Route: single
Dose: 2 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
Respiration spontaneous decreased
2 % 1 times / day single, intraurethral
Recommended
Dose: 2 %, 1 times / day
Route: intraurethral
Route: single
Dose: 2 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
Spasms
2 % 1 times / day single, intraurethral
Recommended
Dose: 2 %, 1 times / day
Route: intraurethral
Route: single
Dose: 2 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://pubmed.ncbi.nlm.nih.gov/18737364/
Cyanosis
10 % 1 times / day single, intraurethral
Studied dose
Dose: 10 %, 1 times / day
Route: intraurethral
Route: single
Dose: 10 %, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
healthy, adult
Health Status: healthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
Generalised convulsion
10 % 1 times / day single, intraurethral
Studied dose
Dose: 10 %, 1 times / day
Route: intraurethral
Route: single
Dose: 10 %, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
healthy, adult
Health Status: healthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
Respiration spontaneous decreased
10 % 1 times / day single, intraurethral
Studied dose
Dose: 10 %, 1 times / day
Route: intraurethral
Route: single
Dose: 10 %, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
healthy, adult
Health Status: healthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/453290
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L1ZKO
Chemieliva Pharmaceutical Co., Ltd
PBCM1028265
ChemMol
99178506
http://www.chemmol.com/chemmol/99178506.html
ChemTik
CTK5H8665
eNovation Chemicals
K79446
https://www.enovationchem.com/ProductDetails.asp?ProductID=K79446
NovoSeek
12428
PubChem
12428
https://pubchem.ncbi.nlm.nih.gov/compound/12428
Smolecule
S518842
http://www.smolecule.com/products/s518842
THE BioTek
bt-259885
https://www.thebiotek.com/product/inhibitors/bt-259885
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:48:11 GMT 2025
Edited
by admin
on Mon Mar 31 22:48:11 GMT 2025
Record UNII
06F0ZZ018S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMYDRICAINE HYDROCHLORIDE
Common Name English
ALIPINE
Preferred Name English
AMYDRICAINE MONOHYDROCHLORIDE
Common Name English
2-BUTANOL, 1-(DIMETHYLAMINO)-2-((DIMETHYLAMINO)METHYL)-, BENZOATE, HYDROCHLORIDE
Systematic Name English
2-BUTANOL, 1-(DIMETHYLAMINO)-2-((DIMETHYLAMINO)METHYL)-, BENZOATE (ESTER), MONOHYDROCHLORIDE
Systematic Name English
2-BUTANOL, 1-(DIMETHYLAMINO)-2-((DIMETHYLAMINO)METHYL)-, BENZOATE (ESTER), HYDROCHLORIDE
Common Name English
ALYPIN HYDROCHLORIDE
Common Name English
2-BUTANOL, 1-(DIMETHYLAMINO)-2-((DIMETHYLAMINO)METHYL)-, 2-BENZOATE, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
CAS
631-38-9
Created by admin on Mon Mar 31 22:48:11 GMT 2025 , Edited by admin on Mon Mar 31 22:48:11 GMT 2025
PRIMARY
FDA UNII
06F0ZZ018S
Created by admin on Mon Mar 31 22:48:11 GMT 2025 , Edited by admin on Mon Mar 31 22:48:11 GMT 2025
PRIMARY
ECHA (EC/EINECS)
211-156-6
Created by admin on Mon Mar 31 22:48:11 GMT 2025 , Edited by admin on Mon Mar 31 22:48:11 GMT 2025
PRIMARY
CAS
74195-82-7
Created by admin on Mon Mar 31 22:48:11 GMT 2025 , Edited by admin on Mon Mar 31 22:48:11 GMT 2025
NON-SPECIFIC STOICHIOMETRY
PUBCHEM
12427
Created by admin on Mon Mar 31 22:48:11 GMT 2025 , Edited by admin on Mon Mar 31 22:48:11 GMT 2025
PRIMARY
Related Record Type Details
Structure of AMYDRICAINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966